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A B S T R A C T
A DAND5-control human iPSC line was generated from the urinary cells of a phenotypically normal donor.
Exfoliated renal epithelial (RE) cells were collected and reprogrammed into iPSCs using Sendai virus repro-
gramming system. The pluripotency, in vitro differentiation potential, karyotype stability, and the transgene-free
status of generated iPSC line were analyzed and confirmed. This cell line can be exploited as a control iPSC line
to better understand the mechanisms involved in DAND5-associated cardiac disease.
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Institution CEDOC, NOVA Medical School
Contact information of
distributor
José A. Belo, jose.belo@nms.unl.pt
Type of cell line iPSC
Origin Human
Additional origin info Sex: male
Ethnicity: Caucasian





Transgene-free (Sendai virus vector)
Genetic Modification NO
Type of Modification N/A
Associated disease N/A
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Resource utility
This DAND5-control iPSC line is essential in studying the disease
related impairment in heart formation of DAND5 found in a previous
study. This control cell line will allow to uncover the role of DAND5
c.455 G>A variant in the molecular mechanisms of cardiomyocyte
proliferation along with the previously established line.
Resource details
DAND5 is a Nodal antagonist that is involved in the correct left/
right body axis establishment during gastrulation (Belo et al., 2017).
The heart is the first organ to be formed and the first organ to be af-
fected by improper levels of Nodal signaling throughout embryo de-
velopment. Several variants of different genes involved in this signaling
pathway have been associated with Congenital Heart Disease (Deng
et al., 2015). Recently, we have identified and functionally character-
ized a c.455G>A DAND5-variant in a patient diagnosed with ven-
tricular septal defect with overriding aorta, right ventricular hyper-
trophy, and pulmonary atresia (a case of extreme tetralogy of Fallot
phenotype) (Cristo et al., 2017a). The variant was inherited from the
apparently healthy mother. To further study the impact of altered
DAND5 proteins in molecular pathways that are involved in cardiac
development and on cardiomyocyte behavior, we have generated and
characterized the NMSUNLi001-A variant cell line, which has a het-
erozygous non-synonymous variant in exon 2 of DAND5 gene
(c.455G>A), causing an amino acid change of p.R152H in the func-
tional domain of the DAND5 protein (Cristo et al., 2017b). However, to
unveil the precise mechanism of how this variant affects early heart
development, the generation of control iPSC lines is essential. Here, we
generated and characterized a DAND5 patient-related (father) control
iPSC line that does not carry any alteration in the locus of the variant
described in the NMSUNLi001-A cell line. This cell line will be utilized
for disease modeling purpose. Hence, exfoliated renal epithelial (RE)
cells were collected from urine sample collected from a healthy donor.
After being grown during 7 days in culture, the RE cells were repro-
grammed using CytoTune™-iPS 2.0 Reprogramming Kit (Life Technol-
ogies, Invitrogen). The kit utilizes non-transmissible, non-integrating
form of Sendai Virus (SeV) vectors that deliver four key transcription
factors (SOX2, OCT3/4, c-MYC and KFL-4) to reprogram the somatic
cells into a pluripotent state, and the iPSC colonies appeared 17 days
after the delivery of the reprogramming factors. At this time, we ob-
served that cells assumed typical stem cell morphology. To obtain
homogeneous and clonal iPSCs lines, we manually picked and expanded
several single cell-derived iPSCs colonies. Among those, one sub-clone
that best displayed the ESC-like morphology (Fig. 1A) was chosen for
further characterization. Firstly, after 27 passages in culture, DNA
Sanger sequencing and karyotype analysis proved the genotype 455G in
DAND5 exon 2 (Fig. 1D), and the number (46, XY) and arrangement of
chromosomes (Fig. 1C). We assessed the transgene-free status of the
iPSC line by qPCR (Fig. 1E), confirming the clearance of the viral
vectors. Since the cytoplasmic nature of SeV only allows the exogenous
reprogramming vectors to be cleared after several passages, we used an
early passage of iPSCs as a positive control. The pluripotency of the
cells was analyzed by both fluorescence immunocytochemistry (Fig. 1F)
and qPCR (Fig. 1B). We confirmed the expression of the key plur-
ipotency factors OCT4, NANOG, and SSEA4 both at protein and mRNA
level. At mRNA level, we additionally confirmed the expression of
pluripotency markers NODAL and SOX2. Embryoid body (EB) forma-
tion assay was performed to assess the spontaneous differentiation
potential of the iPSCs in vitro. From this assay, we assessed that the EBs
cultured for 19 days expressed markers of the three germ layers: en-
doderm, mesoderm, ectoderm, i.e., alpha-fetoprotein (AFP), smooth
muscle actin (SMA), tubulin beta-3 chain (TUBB3), respectively
(Fig. 1G). Finally, STR analysis was performed showing that all the 16
loci tested matched (Table 1) .
Materials and methods
Reprogramming of RE cells
RE cells were collected and expanded in culture. After ~4 days in
culture, cells started to become evident and the medium was changed to
REBM™ supplemented with REGM™ BulletKit (Lonza). When cells
reached ~80% confluency, they were seeded on a 6-well plate and
reprogrammed using CytoTune™-iPS 2.0 Sendai Reprogramming Kit
(Life Technologies). At day 8 post-transduction, cells were passaged
onto a 100mm culture dish coated with Geltrex (Gibco, Thermo Fisher
Scientific) and the next day medium was changed to Essential 8™ (E8)
Flex medium, replaced until the iPSCs have emerged. 17 days post-
transduction, colonies that best display an ESC-like morphology were
picked and expanded with daily renewal of the E8 Flex medium.
Sequencing
To confirm the absence of the c.455G nucleotide in the established
DAND5-control cell line, genomic DNA was extracted using ISOLATE II
Genomic DNA kit (Bioline). Then, using the primers indicated in
Table 2, exon 2 of DAND5 was amplified by PCR and purified using
NZYGelpure kit (NZYTech). Sequencing was conducted by STAB VIDA
(http://www.stabvida.com/).
RNA extraction and real time qRT-PCR
The clearance of SeV transgenes and the expression of pluripotency
markers OCT4, NANOG, SSEA4 (primers listed in Table 2) were carried
out using Direct-zol™ RNA MiniPrep (Zymo Research). Subsequently,
reverse transcription and qRT-PCR were performed.
Embryoid body formation assay
Embryoid bodies (EBs) consisting of approximately 2000 iPS cells/
20 μl drop in Essential 8™ (E8) medium with 4mg/ml polyvinylalcohol
and RevitaCell™ Supplement (Thermo Fisher Scientific) were generated
using hanging drop method. After 2 days, EBs were suspended in 50%
E8 medium and 50% differentiation medium (DMEM with 20% FBS,
Pen/Strep, NEAA, 2mM L-glutamine, and 0,1 mM β-mercaptoethanol)
and grown 3 more days. At day 5, EBs were placed on 24-well-plate
with differentiation medium changes every other day. By day 19, EBs
were fixed with 4% formaldehyde and the immunocytochemistry as-
sayed for the three germ layers AFP, SMA and TUBB3.
Fluorescent immunocytochemistry (ICC)
Cells were fixed with 4% paraformaldehyde, permeabilized, blocked
and incubated with primary and secondary antibodies (listed in
Table 2) overnight at 4 °C. Prior to image acquisition, DAPI was used to
stain DNA. All fluorescent images were acquired with confocal micro-
scopy.
Karyotyping
Chromosome analysis was performed using GTG high resolution
banding technique, according to standard procedures with a minimum
of 10 metaphase spreads analyzed. Analysis of GTG-banded chromo-
somes was performed at a resolution of 400 bands per haploid genome
and karyotypes were established according to the International System
for Human Cytogenetic Nomenclature (ISCN 2016).
Mycoplasma contamination test
The sterility of the iPSC culture from mycoplasma was verified by
PCR using the primers in Table 2.
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Fig. 1. Characterization of the iUC-DAND5_455/control iPSC line. A. Morphology of the iUC-DAND5_455/control line. B. mRNA expression levels of endogenous
pluripotency markers in H9 cells (Black - positive control), ERE cells (Blue) and iUC-DAND5_455/control line (Red). CT-values were normalized to the geometric
mean of the two housekeeping genes GAPDH and β-actin and with H9 human embryonic stem cell line as reference (set to 1). C. Karyotype of representative
metaphase showing normal 46 chromosomes (XY). D. DNA sequence confirming the normal homozygous c.455G genotype in the iUC-DAND5_455/control line. E.
Absolute quantitative real-time PCR showing absence of the vectors and the exogenous reprogramming factor in iPSCs (right) and presence of the reprogramming
factors in the EREr control cells (left). F. Immunodetection of pluripotency markers of iUC-DAND5_455/control line. G. Immunofluorescence analyses of in vitro
differentiation of EBs using specific antibodies against the endodermal marker α-fetoprotein (AFP), ectodermal marker βIII-tubulin (TUBB3) and mesodermal
markers α-smooth muscle actin (SMA). Nuclei were stained with DAPI (scale bars= 20µm).
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STR analysis
iUC-DAND5_455/control cells and the corresponding ERE cells were
authenticated by STR analysis performed by STAB VIDA (http://www.
stabvida.com/).
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.scr.2018.04.015.
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Table 1
Characterization and validation.
Classification Test Result Data
Morphology Photography ESC-like morphology Fig. 1, panel A
Phenotype Immunocytochemistry Staining of pluripotency markers: Oct4, Nanog, SSEA4 Fig. 1, panel F
qPCR Expression of pluripotency markers: NANOG, OCT3/4, SOX2, KLF4 and
NODAL
Fig. 1, panel B
Genotype Karyotype (G-banding) and resolution 46XY, Resolution 400–500 Fig. 1, panel C
Identity Microsatellite PCR (mPCR) N/A




Sequencing Homozygous (G > G) Fig. 1, panel D
Southern Blot OR WGS N/A, Non-integrating reprogramming methodology
Microbiology and virology Mycoplasma contamination Mycoplasma-free culture Supplementary Fig. S1 panel
B
Differentiation potential Embryoid body formation Proof of formation of three germ layers from Embryoid bodies: α-
fetoprotein (AFP), βIII-tubulin (TUBB3), α-smooth muscle actin (SMA).
Fig. 1, panel G
Donor screening (OPTIONAL) HIV 1+2 Hepatitis B, Hepatitis C N/A N/A
Genotype additional info
(OPTIONAL)
Blood group genotyping N/A N/A
HLA tissue typing N/A N/A
Table 2
Reagents details.
Antibodies used for immunocytochemistry/flow-citometry
Antibody Dilution Company Cat # and RRID
Pluripotency Markers Rabbit anti-NANO 1:200 Abcam Cat# ab21624, RRID:AB_446437
Rabbit anti-OCT4 1:400 Abcam Cat# ab19857, RRID:AB_445175
Mouse anti-SSEA4 1:200 Abcam Cat# ab16287, RRID:AB_778073
Differentiation Markers Mouse anti-Human TUBB3 1:400 Sigma-Aldrich Cat# T8660, RRID:AB_477590
Mouse anti-Human SMA 1:600 Dako Cat# M0851, RRID:AB_2223500
Rabbit anti-Human AFP 1:200 Dako Cat# A0008, RRID:AB_2650473
Secondary antibodies Alexa Fluor 488-conjugated Donkey anti-Mouse IgG (H+L) 1:300 Jackson ImmunoResearch Labs Cat# 715–545-150, RRID:AB_2340846
Alexa Fluor 488-conjugated Donkey anti-Rabbit IgG (H+ L) 1:300 Jackson ImmunoResearch Labs Cat# 711–545-152, RRID:AB_2313584
Primers
Target Forward/Reverse primer (5′-3′)









House-Keeping Genes (qPCR) GAPDH CTGGTAAAGTGGATATTGTTGCCAT/TGGAATCATATTGGAACATGTAAACC
β-actin GCAAAGACCTGTACGCCAAC/AGTACTTGCGCTCAGGAGGA
Mycoplasma detection Pair 1 CTGCAGATTGCAAAGCAAGA/CCTCCTTCTTCACCTGCTTG
Pair 2 GGCGAATGGGTGAGTAACACG/CGGATAACGCTTGCGACCTATG
Targeted mutation analysis/sequencing DAND5 exon 2 GGAAGTGGACAGGTGATTATCC/CAC
GTCTTTCTTGGTCCATCTC
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